Shao‐Lai Zhou

5.3k total citations · 1 hit paper
58 papers, 3.7k citations indexed

About

Shao‐Lai Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shao‐Lai Zhou has authored 58 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Shao‐Lai Zhou's work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (12 papers) and Circular RNAs in diseases (9 papers). Shao‐Lai Zhou is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (12 papers) and Circular RNAs in diseases (9 papers). Shao‐Lai Zhou collaborates with scholars based in China, Ethiopia and United States. Shao‐Lai Zhou's co-authors include Jia Fan, Zheng‐Jun Zhou, Jian Zhou, Xiaowu Huang, Zhiqiang Hu, Zhi Dai, Ya Cao, Zheng Wang, Erbao Chen and Chu‐Bin Luo and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shao‐Lai Zhou

57 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib

2016 662 citations Shao‐Lai Zhou, Zheng‐Jun Zhou et al. profile →

Peers

Shao‐Lai Zhou

ONCOL

IMMUN

HEPAT

Guo‐Ming Shi China

Eric A. Severson United States

Dong‐Ming Kuang China

Shuang‐Jian Qiu China

Eishi Nagai Japan

Guo‐Huan Yang China

Qiyi Zhao China

Binkui Li China

Naoki Ikenaga Japan

Seung Myung Dong South Korea

Guo‐Ming Shi China

Shao‐Lai Zhou

1.8k ×1.1

740 ×0.5

ONCOL

1.2k ×0.9

332 ×0.3

IMMUN

483 ×0.8

HEPAT

Citations per year, relative to Shao‐Lai Zhou Shao‐Lai Zhou (= 1×) peers Guo‐Ming Shi

Countries citing papers authored by Shao‐Lai Zhou

Since Specialization

Citations

This map shows the geographic impact of Shao‐Lai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Lai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Lai Zhou more than expected).

Fields of papers citing papers by Shao‐Lai Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao‐Lai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Lai Zhou. The network helps show where Shao‐Lai Zhou may publish in the future.

Co-authorship network of co-authors of Shao‐Lai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shao‐Lai Zhou. A scholar is included among the top collaborators of Shao‐Lai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao‐Lai Zhou. Shao‐Lai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Zheng‐Jun, Zhiqiang Hu, Yayi Hou, et al.. (2024). Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver. Nature Communications. 15(1). 9960–9960. 4 indexed citations

Ling, Chen, Cong Wang, Yun He, et al.. (2024). rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination. Nucleic Acids Research. 52(11). 6518–6531. 6 indexed citations

Hu, Zhiqiang, Songyang Yu, Hezhi Wang, et al.. (2024). A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma. Cancer Letters. 598. 217092–217092. 13 indexed citations

Pan, Si-Yuan, et al.. (2024). Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon. Hepatoma Research. 1 indexed citations

Yu, Songyang, Peng‐Cheng Wang, Jia Li, et al.. (2024). Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma. Cancer Letters. 591. 216872–216872. 11 indexed citations

Sun, Rongqi, Ye Xu, Bo Wang, et al.. (2024). Integrated molecular characterization of sarcomatoid hepatocellular carcinoma. Clinical and Molecular Hepatology. 31(2). 426–444. 2 indexed citations

Xin, Haoyang, Ning Li, Si-Yuan Pan, et al.. (2024). Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma. Clinical and Molecular Hepatology. 30(4). 914–928. 1 indexed citations

Xin, Haoyang, Rongqi Sun, Pengcheng Wang, et al.. (2023). Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma. JAMA Network Open. 6(3). e231476–e231476. 22 indexed citations

Li, Jia, Zhiqiang Hu, Songyang Yu, et al.. (2022). CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma. Cancer Research. 82(6). 1055–1069. 100 indexed citations

10.

Zhou, Shao‐Lai, Zheng‐Jun Zhou, Chengli Song, et al.. (2022). Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence. Signal Transduction and Targeted Therapy. 7(1). 24–24. 22 indexed citations

11.

Hu, Zhiqiang, Shao‐Lai Zhou, Songyang Yu, et al.. (2021). The spatial distribution of immune cell subpopulations in hepatocellular carcinoma. Cancer Science. 113(2). 423–431. 17 indexed citations

12.

Hu, Zhiqiang, Haoyang Xin, Chu‐Bin Luo, et al.. (2020). Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 70(2). 377–389. 31 indexed citations

13.

Hu, Zhiqiang, Zheng‐Jun Zhou, Chu‐Bin Luo, et al.. (2020). Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection. Cancer Cell International. 20(1). 582–582. 20 indexed citations

14.

Zhou, Zheng‐Jun, Chu‐Bin Luo, Haoyang Xin, et al.. (2020). MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling. npj Genomic Medicine. 5(1). 15–15. 14 indexed citations

15.

Zhu, Gui‐Qi, Yi Yang, Erbao Chen, et al.. (2019). Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Journal of Translational Medicine. 17(1). 203–203. 16 indexed citations

16.

Wang, Zheng, Zhenggang Ren, Yi Chen, et al.. (2018). Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study. Clinical Cancer Research. 24(9). 2074–2081. 204 indexed citations

17.

Zhu, Guiqi, Kang Wang, Yujie Zhou, et al.. (2018). Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization. Cancer Management and Research. Volume 11. 63–79. 12 indexed citations

18.

Huang, Ao, Xin Zhang, Shao‐Lai Zhou, et al.. (2016). Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma. Journal of Cancer. 7(13). 1798–1803. 68 indexed citations

19.

Zhou, Zheng‐Jun, Zhi Dai, Shao‐Lai Zhou, et al.. (2014). HNRNPAB Induces Epithelial–Mesenchymal Transition and Promotes Metastasis of Hepatocellular Carcinoma by Transcriptionally Activating SNAIL. Cancer Research. 74(10). 2750–2762. 88 indexed citations

20.

Xu, Min, Chang‐Jun Tan, Jian Zhou, et al.. (2009). The dynamic changes of T-bet+/GATA-3+ and RORγt+/FOXP3+ cells in recipient spleens and grafts after rat orthotopic liver transplantation. Transplant Immunology. 22(3-4). 165–171. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact